nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—ABCB1—Dactinomycin—muscle cancer	0.0702	0.247	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—muscle cancer	0.0527	0.185	CbGbCtD
Promethazine—ABCB1—Vincristine—muscle cancer	0.0432	0.152	CbGbCtD
Promethazine—ABCB1—Etoposide—muscle cancer	0.0396	0.139	CbGbCtD
Promethazine—CHRM3—muscle of abdomen—muscle cancer	0.0336	0.145	CbGeAlD
Promethazine—ABCB1—Doxorubicin—muscle cancer	0.027	0.095	CbGbCtD
Promethazine—ABCB1—Methotrexate—muscle cancer	0.0262	0.092	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—muscle cancer	0.0255	0.0895	CbGbCtD
Promethazine—HRH4—bone marrow—muscle cancer	0.0125	0.0539	CbGeAlD
Promethazine—HTR2A—hindlimb—muscle cancer	0.0102	0.044	CbGeAlD
Promethazine—HTR2A—appendage—muscle cancer	0.00876	0.0377	CbGeAlD
Promethazine—Paralysis—Vincristine—muscle cancer	0.00611	0.0245	CcSEcCtD
Promethazine—Necrosis—Dactinomycin—muscle cancer	0.00605	0.0243	CcSEcCtD
Promethazine—CHRM4—head—muscle cancer	0.00568	0.0245	CbGeAlD
Promethazine—CHRM4—testis—muscle cancer	0.00548	0.0236	CbGeAlD
Promethazine—Extravasation—Dactinomycin—muscle cancer	0.00545	0.0218	CcSEcCtD
Promethazine—Sensory loss—Vincristine—muscle cancer	0.0049	0.0196	CcSEcCtD
Promethazine—Extravasation—Vincristine—muscle cancer	0.00486	0.0195	CcSEcCtD
Promethazine—CALM3—smooth muscle tissue—muscle cancer	0.0048	0.0207	CbGeAlD
Promethazine—CALM2—embryo—muscle cancer	0.0048	0.0207	CbGeAlD
Promethazine—CALM1—embryo—muscle cancer	0.00477	0.0206	CbGeAlD
Promethazine—Aplastic anaemia—Dactinomycin—muscle cancer	0.00446	0.0179	CcSEcCtD
Promethazine—CHRM5—head—muscle cancer	0.00444	0.0191	CbGeAlD
Promethazine—Necrosis—Etoposide—muscle cancer	0.00438	0.0176	CcSEcCtD
Promethazine—CALM3—cardiac atrium—muscle cancer	0.00414	0.0178	CbGeAlD
Promethazine—Appetite absent—Methotrexate—muscle cancer	0.00414	0.0166	CcSEcCtD
Promethazine—Apnoea—Etoposide—muscle cancer	0.00406	0.0163	CcSEcCtD
Promethazine—Phlebitis—Dactinomycin—muscle cancer	0.004	0.016	CcSEcCtD
Promethazine—Sensory loss—Etoposide—muscle cancer	0.00397	0.0159	CcSEcCtD
Promethazine—Extravasation—Etoposide—muscle cancer	0.00394	0.0158	CcSEcCtD
Promethazine—Coma—Vincristine—muscle cancer	0.00388	0.0156	CcSEcCtD
Promethazine—CHRM3—smooth muscle tissue—muscle cancer	0.00385	0.0166	CbGeAlD
Promethazine—CALM2—smooth muscle tissue—muscle cancer	0.00377	0.0162	CbGeAlD
Promethazine—CALM1—smooth muscle tissue—muscle cancer	0.00375	0.0162	CbGeAlD
Promethazine—CHRM3—renal system—muscle cancer	0.00371	0.016	CbGeAlD
Promethazine—CALM2—renal system—muscle cancer	0.00363	0.0156	CbGeAlD
Promethazine—CALM1—renal system—muscle cancer	0.00361	0.0156	CbGeAlD
Promethazine—CALM3—tendon—muscle cancer	0.00361	0.0155	CbGeAlD
Promethazine—CALM3—bone marrow—muscle cancer	0.0035	0.0151	CbGeAlD
Promethazine—ADRA1A—renal system—muscle cancer	0.0034	0.0147	CbGeAlD
Promethazine—CALM3—vagina—muscle cancer	0.00335	0.0144	CbGeAlD
Promethazine—Venous thrombosis—Doxorubicin—muscle cancer	0.0033	0.0132	CcSEcCtD
Promethazine—CALM2—cardiac atrium—muscle cancer	0.00325	0.014	CbGeAlD
Promethazine—CALM1—cardiac atrium—muscle cancer	0.00324	0.0139	CbGeAlD
Promethazine—CHRM2—head—muscle cancer	0.00305	0.0131	CbGeAlD
Promethazine—CALM3—testis—muscle cancer	0.00299	0.0129	CbGeAlD
Promethazine—Paralysis—Methotrexate—muscle cancer	0.00296	0.0119	CcSEcCtD
Promethazine—Urinary retention—Vincristine—muscle cancer	0.00293	0.0117	CcSEcCtD
Promethazine—HTR2A—embryo—muscle cancer	0.00291	0.0125	CbGeAlD
Promethazine—Phlebitis—Etoposide—muscle cancer	0.0029	0.0116	CcSEcCtD
Promethazine—CALM2—tendon—muscle cancer	0.00283	0.0122	CbGeAlD
Promethazine—Swelling—Etoposide—muscle cancer	0.00283	0.0113	CcSEcCtD
Promethazine—CALM1—tendon—muscle cancer	0.00282	0.0122	CbGeAlD
Promethazine—CHRM1—head—muscle cancer	0.00277	0.0119	CbGeAlD
Promethazine—CALM2—bone marrow—muscle cancer	0.00274	0.0118	CbGeAlD
Promethazine—HRH1—smooth muscle tissue—muscle cancer	0.00274	0.0118	CbGeAlD
Promethazine—CALM1—bone marrow—muscle cancer	0.00273	0.0118	CbGeAlD
Promethazine—CYP2B6—renal system—muscle cancer	0.0027	0.0116	CbGeAlD
Promethazine—CALM2—vagina—muscle cancer	0.00263	0.0113	CbGeAlD
Promethazine—Necrosis—Methotrexate—muscle cancer	0.00262	0.0105	CcSEcCtD
Promethazine—CALM1—vagina—muscle cancer	0.00262	0.0113	CbGeAlD
Promethazine—Abscess—Methotrexate—muscle cancer	0.0026	0.0104	CcSEcCtD
Promethazine—Paralysis—Doxorubicin—muscle cancer	0.00257	0.0103	CcSEcCtD
Promethazine—CHRM3—head—muscle cancer	0.00248	0.0107	CbGeAlD
Promethazine—Agranulocytosis—Dactinomycin—muscle cancer	0.00248	0.00994	CcSEcCtD
Promethazine—Photosensitivity reaction—Vincristine—muscle cancer	0.00243	0.00975	CcSEcCtD
Promethazine—Apnoea—Methotrexate—muscle cancer	0.00243	0.00974	CcSEcCtD
Promethazine—CALM2—head—muscle cancer	0.00243	0.0105	CbGeAlD
Promethazine—CALM1—head—muscle cancer	0.00242	0.0104	CbGeAlD
Promethazine—CHRM3—testis—muscle cancer	0.0024	0.0103	CbGeAlD
Promethazine—Depression—Vincristine—muscle cancer	0.00237	0.00949	CcSEcCtD
Promethazine—Extravasation—Methotrexate—muscle cancer	0.00236	0.00946	CcSEcCtD
Promethazine—CALM2—testis—muscle cancer	0.00235	0.0101	CbGeAlD
Promethazine—CALM1—testis—muscle cancer	0.00234	0.0101	CbGeAlD
Promethazine—HTR2A—smooth muscle tissue—muscle cancer	0.00229	0.00985	CbGeAlD
Promethazine—ADRA1A—head—muscle cancer	0.00228	0.00982	CbGeAlD
Promethazine—Necrosis—Doxorubicin—muscle cancer	0.00227	0.00911	CcSEcCtD
Promethazine—Abscess—Doxorubicin—muscle cancer	0.00225	0.00904	CcSEcCtD
Promethazine—DRD2—head—muscle cancer	0.00223	0.00962	CbGeAlD
Promethazine—HTR2A—renal system—muscle cancer	0.0022	0.00949	CbGeAlD
Promethazine—DRD2—testis—muscle cancer	0.00216	0.0093	CbGeAlD
Promethazine—Hallucination—Vincristine—muscle cancer	0.00212	0.0085	CcSEcCtD
Promethazine—Erythema—Dactinomycin—muscle cancer	0.00208	0.00833	CcSEcCtD
Promethazine—Delirium—Doxorubicin—muscle cancer	0.00207	0.00831	CcSEcCtD
Promethazine—HRH1—tendon—muscle cancer	0.00206	0.00887	CbGeAlD
Promethazine—Extravasation—Doxorubicin—muscle cancer	0.00204	0.0082	CcSEcCtD
Promethazine—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00203	0.00814	CcSEcCtD
Promethazine—CYP2D6—renal system—muscle cancer	0.00201	0.00864	CbGeAlD
Promethazine—CYP2B6—vagina—muscle cancer	0.00195	0.00842	CbGeAlD
Promethazine—Aplastic anaemia—Methotrexate—muscle cancer	0.00193	0.00775	CcSEcCtD
Promethazine—HRH1—vagina—muscle cancer	0.00191	0.00823	CbGeAlD
Promethazine—ABCB1—embryo—muscle cancer	0.00191	0.00821	CbGeAlD
Promethazine—Dyskinesia—Doxorubicin—muscle cancer	0.0019	0.00761	CcSEcCtD
Promethazine—Coma—Methotrexate—muscle cancer	0.00188	0.00755	CcSEcCtD
Promethazine—Jaundice—Etoposide—muscle cancer	0.00187	0.00752	CcSEcCtD
Promethazine—Leukopenia—Dactinomycin—muscle cancer	0.00186	0.00745	CcSEcCtD
Promethazine—Coordination abnormal—Doxorubicin—muscle cancer	0.00182	0.00728	CcSEcCtD
Promethazine—CYP2B6—head—muscle cancer	0.00181	0.00778	CbGeAlD
Promethazine—Agranulocytosis—Etoposide—muscle cancer	0.00179	0.0072	CcSEcCtD
Promethazine—Injection site reaction—Doxorubicin—muscle cancer	0.00177	0.00711	CcSEcCtD
Promethazine—HRH1—head—muscle cancer	0.00176	0.0076	CbGeAlD
Promethazine—Dermatitis contact—Doxorubicin—muscle cancer	0.00176	0.00707	CcSEcCtD
Promethazine—CYP2B6—testis—muscle cancer	0.00174	0.00752	CbGeAlD
Promethazine—Thrombophlebitis—Methotrexate—muscle cancer	0.00173	0.00692	CcSEcCtD
Promethazine—HTR2A—tendon—muscle cancer	0.00172	0.0074	CbGeAlD
Promethazine—Agitation—Vincristine—muscle cancer	0.00171	0.00684	CcSEcCtD
Promethazine—HRH1—testis—muscle cancer	0.0017	0.00734	CbGeAlD
Promethazine—Photosensitivity—Methotrexate—muscle cancer	0.0017	0.00683	CcSEcCtD
Promethazine—Oedema—Dactinomycin—muscle cancer	0.00169	0.0068	CcSEcCtD
Promethazine—Aplastic anaemia—Doxorubicin—muscle cancer	0.00167	0.00671	CcSEcCtD
Promethazine—Leukopenia—Vincristine—muscle cancer	0.00166	0.00666	CcSEcCtD
Promethazine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00166	0.00665	CcSEcCtD
Promethazine—Coma—Doxorubicin—muscle cancer	0.00163	0.00653	CcSEcCtD
Promethazine—Convulsion—Vincristine—muscle cancer	0.00161	0.00645	CcSEcCtD
Promethazine—HTR2A—vagina—muscle cancer	0.00159	0.00687	CbGeAlD
Promethazine—Anaphylactic shock—Vincristine—muscle cancer	0.00151	0.00607	CcSEcCtD
Promethazine—Oedema—Vincristine—muscle cancer	0.00151	0.00607	CcSEcCtD
Promethazine—Phlebitis—Doxorubicin—muscle cancer	0.0015	0.00602	CcSEcCtD
Promethazine—Thrombophlebitis—Doxorubicin—muscle cancer	0.0015	0.006	CcSEcCtD
Promethazine—Thrombocytopenia—Vincristine—muscle cancer	0.00148	0.00594	CcSEcCtD
Promethazine—Photosensitivity—Doxorubicin—muscle cancer	0.00147	0.00591	CcSEcCtD
Promethazine—Decreased appetite—Dactinomycin—muscle cancer	0.00147	0.00591	CcSEcCtD
Promethazine—HTR2A—head—muscle cancer	0.00147	0.00635	CbGeAlD
Promethazine—Fatigue—Dactinomycin—muscle cancer	0.00146	0.00586	CcSEcCtD
Promethazine—Pain—Dactinomycin—muscle cancer	0.00145	0.00581	CcSEcCtD
Promethazine—Muscle spasms—Etoposide—muscle cancer	0.00145	0.00579	CcSEcCtD
Promethazine—ABCB1—renal system—muscle cancer	0.00144	0.00622	CbGeAlD
Promethazine—Irritability—Methotrexate—muscle cancer	0.00143	0.00572	CcSEcCtD
Promethazine—HTR2A—testis—muscle cancer	0.00142	0.00613	CbGeAlD
Promethazine—Hypotension—Vincristine—muscle cancer	0.00142	0.00567	CcSEcCtD
Promethazine—Feeling abnormal—Dactinomycin—muscle cancer	0.0014	0.0056	CcSEcCtD
Promethazine—Insomnia—Vincristine—muscle cancer	0.00137	0.00549	CcSEcCtD
Promethazine—Leukopenia—Etoposide—muscle cancer	0.00135	0.00539	CcSEcCtD
Promethazine—CYP2D6—head—muscle cancer	0.00134	0.00578	CbGeAlD
Promethazine—Loss of consciousness—Etoposide—muscle cancer	0.00132	0.0053	CcSEcCtD
Promethazine—Decreased appetite—Vincristine—muscle cancer	0.00132	0.00528	CcSEcCtD
Promethazine—Fatigue—Vincristine—muscle cancer	0.00131	0.00523	CcSEcCtD
Promethazine—Convulsion—Etoposide—muscle cancer	0.0013	0.00522	CcSEcCtD
Promethazine—CYP2D6—testis—muscle cancer	0.0013	0.00559	CbGeAlD
Promethazine—Pain—Vincristine—muscle cancer	0.00129	0.00519	CcSEcCtD
Promethazine—Constipation—Vincristine—muscle cancer	0.00129	0.00519	CcSEcCtD
Promethazine—Diplopia—Doxorubicin—muscle cancer	0.00129	0.00519	CcSEcCtD
Promethazine—Asthma—Methotrexate—muscle cancer	0.00129	0.00518	CcSEcCtD
Promethazine—Confusional state—Etoposide—muscle cancer	0.00124	0.00496	CcSEcCtD
Promethazine—Anaphylactic shock—Etoposide—muscle cancer	0.00123	0.00492	CcSEcCtD
Promethazine—Asthenia—Dactinomycin—muscle cancer	0.00122	0.00488	CcSEcCtD
Promethazine—Thrombocytopenia—Etoposide—muscle cancer	0.0012	0.00482	CcSEcCtD
Promethazine—Tachycardia—Etoposide—muscle cancer	0.0012	0.0048	CcSEcCtD
Promethazine—Photosensitivity reaction—Methotrexate—muscle cancer	0.00118	0.00473	CcSEcCtD
Promethazine—Diarrhoea—Dactinomycin—muscle cancer	0.00116	0.00465	CcSEcCtD
Promethazine—Drowsiness—Methotrexate—muscle cancer	0.00115	0.00462	CcSEcCtD
Promethazine—Depression—Methotrexate—muscle cancer	0.00115	0.00461	CcSEcCtD
Promethazine—Hypotension—Etoposide—muscle cancer	0.00115	0.0046	CcSEcCtD
Promethazine—Asthma—Doxorubicin—muscle cancer	0.00112	0.00449	CcSEcCtD
Promethazine—ABCB1—bone marrow—muscle cancer	0.00109	0.0047	CbGeAlD
Promethazine—Somnolence—Etoposide—muscle cancer	0.00109	0.00437	CcSEcCtD
Promethazine—Asthenia—Vincristine—muscle cancer	0.00109	0.00436	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—muscle cancer	0.00108	0.00431	CcSEcCtD
Promethazine—Rash—Dactinomycin—muscle cancer	0.00107	0.00428	CcSEcCtD
Promethazine—Decreased appetite—Etoposide—muscle cancer	0.00107	0.00428	CcSEcCtD
Promethazine—Fatigue—Etoposide—muscle cancer	0.00106	0.00424	CcSEcCtD
Promethazine—Constipation—Etoposide—muscle cancer	0.00105	0.00421	CcSEcCtD
Promethazine—Pain—Etoposide—muscle cancer	0.00105	0.00421	CcSEcCtD
Promethazine—ABCB1—vagina—muscle cancer	0.00104	0.0045	CbGeAlD
Promethazine—Diarrhoea—Vincristine—muscle cancer	0.00104	0.00415	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00102	0.00409	CcSEcCtD
Promethazine—Feeling abnormal—Etoposide—muscle cancer	0.00101	0.00405	CcSEcCtD
Promethazine—Dizziness—Vincristine—muscle cancer	0.001	0.00402	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—muscle cancer	0.000998	0.004	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—muscle cancer	0.000972	0.0039	CcSEcCtD
Promethazine—ABCB1—head—muscle cancer	0.000965	0.00416	CbGeAlD
Promethazine—Tinnitus—Methotrexate—muscle cancer	0.000964	0.00387	CcSEcCtD
Promethazine—Rash—Vincristine—muscle cancer	0.000955	0.00383	CcSEcCtD
Promethazine—Dermatitis—Vincristine—muscle cancer	0.000954	0.00382	CcSEcCtD
Promethazine—Headache—Vincristine—muscle cancer	0.000949	0.0038	CcSEcCtD
Promethazine—ABCB1—testis—muscle cancer	0.000932	0.00402	CbGeAlD
Promethazine—Agranulocytosis—Doxorubicin—muscle cancer	0.000931	0.00373	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—muscle cancer	0.000912	0.00366	CcSEcCtD
Promethazine—Erythema—Methotrexate—muscle cancer	0.0009	0.00361	CcSEcCtD
Promethazine—Asthenia—Etoposide—muscle cancer	0.00088	0.00353	CcSEcCtD
Promethazine—Pruritus—Etoposide—muscle cancer	0.000868	0.00348	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—muscle cancer	0.000848	0.0034	CcSEcCtD
Promethazine—Diarrhoea—Etoposide—muscle cancer	0.000839	0.00337	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—muscle cancer	0.000835	0.00335	CcSEcCtD
Promethazine—Dizziness—Etoposide—muscle cancer	0.000811	0.00325	CcSEcCtD
Promethazine—Leukopenia—Methotrexate—muscle cancer	0.000806	0.00323	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—muscle cancer	0.0008	0.00321	CcSEcCtD
Promethazine—Convulsion—Methotrexate—muscle cancer	0.00078	0.00313	CcSEcCtD
Promethazine—Erythema—Doxorubicin—muscle cancer	0.00078	0.00313	CcSEcCtD
Promethazine—Rash—Etoposide—muscle cancer	0.000773	0.0031	CcSEcCtD
Promethazine—Dermatitis—Etoposide—muscle cancer	0.000773	0.0031	CcSEcCtD
Promethazine—Headache—Etoposide—muscle cancer	0.000768	0.00308	CcSEcCtD
Promethazine—Tension—Doxorubicin—muscle cancer	0.000765	0.00307	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—muscle cancer	0.000757	0.00304	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—muscle cancer	0.00075	0.00301	CcSEcCtD
Promethazine—Confusional state—Methotrexate—muscle cancer	0.000741	0.00297	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—muscle cancer	0.000735	0.00295	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—muscle cancer	0.000735	0.00295	CcSEcCtD
Promethazine—Thrombocytopenia—Methotrexate—muscle cancer	0.000719	0.00288	CcSEcCtD
Promethazine—Agitation—Doxorubicin—muscle cancer	0.000716	0.00287	CcSEcCtD
Promethazine—Syncope—Doxorubicin—muscle cancer	0.000699	0.0028	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—muscle cancer	0.000698	0.0028	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—muscle cancer	0.000689	0.00276	CcSEcCtD
Promethazine—Hypotension—Methotrexate—muscle cancer	0.000687	0.00275	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—muscle cancer	0.000685	0.00275	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—muscle cancer	0.000675	0.00271	CcSEcCtD
Promethazine—Insomnia—Methotrexate—muscle cancer	0.000665	0.00266	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—muscle cancer	0.000661	0.00265	CcSEcCtD
Promethazine—Somnolence—Methotrexate—muscle cancer	0.000653	0.00262	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—muscle cancer	0.000649	0.0026	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—muscle cancer	0.000647	0.00259	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—muscle cancer	0.000642	0.00257	CcSEcCtD
Promethazine—Decreased appetite—Methotrexate—muscle cancer	0.000639	0.00256	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000636	0.00255	CcSEcCtD
Promethazine—Oedema—Doxorubicin—muscle cancer	0.000636	0.00255	CcSEcCtD
Promethazine—Fatigue—Methotrexate—muscle cancer	0.000633	0.00254	CcSEcCtD
Promethazine—Pain—Methotrexate—muscle cancer	0.000628	0.00252	CcSEcCtD
Promethazine—Shock—Doxorubicin—muscle cancer	0.000626	0.00251	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000623	0.0025	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—muscle cancer	0.000621	0.00249	CcSEcCtD
Promethazine—Feeling abnormal—Methotrexate—muscle cancer	0.000606	0.00243	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—muscle cancer	0.000595	0.00238	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—muscle cancer	0.000575	0.00231	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—muscle cancer	0.000566	0.00227	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—muscle cancer	0.00056	0.00225	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—muscle cancer	0.000553	0.00222	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—muscle cancer	0.000549	0.0022	CcSEcCtD
Promethazine—Pain—Doxorubicin—muscle cancer	0.000544	0.00218	CcSEcCtD
Promethazine—Constipation—Doxorubicin—muscle cancer	0.000544	0.00218	CcSEcCtD
Promethazine—Asthenia—Methotrexate—muscle cancer	0.000527	0.00211	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—muscle cancer	0.000524	0.0021	CcSEcCtD
Promethazine—Pruritus—Methotrexate—muscle cancer	0.00052	0.00208	CcSEcCtD
Promethazine—Diarrhoea—Methotrexate—muscle cancer	0.000503	0.00202	CcSEcCtD
Promethazine—Dizziness—Methotrexate—muscle cancer	0.000486	0.00195	CcSEcCtD
Promethazine—Rash—Methotrexate—muscle cancer	0.000463	0.00186	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—muscle cancer	0.000463	0.00186	CcSEcCtD
Promethazine—Headache—Methotrexate—muscle cancer	0.00046	0.00185	CcSEcCtD
Promethazine—Asthenia—Doxorubicin—muscle cancer	0.000456	0.00183	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—muscle cancer	0.00045	0.0018	CcSEcCtD
Promethazine—Diarrhoea—Doxorubicin—muscle cancer	0.000435	0.00175	CcSEcCtD
Promethazine—Dizziness—Doxorubicin—muscle cancer	0.000421	0.00169	CcSEcCtD
Promethazine—Rash—Doxorubicin—muscle cancer	0.000401	0.00161	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—muscle cancer	0.000401	0.00161	CcSEcCtD
Promethazine—Headache—Doxorubicin—muscle cancer	0.000399	0.0016	CcSEcCtD
Promethazine—CALM2—Signaling by NGF—KIT—muscle cancer	0.000197	0.000841	CbGpPWpGaD
Promethazine—CALM1—Signaling by NGF—KIT—muscle cancer	0.000197	0.000841	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—FOXO4—muscle cancer	0.000192	0.000819	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—FOXO4—muscle cancer	0.000192	0.000819	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—PTCH1—muscle cancer	0.000187	0.0008	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—PTCH1—muscle cancer	0.000184	0.000787	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—IGF2—muscle cancer	0.000184	0.000786	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—PTCH1—muscle cancer	0.000184	0.000786	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—PTCH1—muscle cancer	0.000183	0.000783	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—PTCH1—muscle cancer	0.000183	0.000781	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—FOXO1—muscle cancer	0.000182	0.000777	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—PTCH1—muscle cancer	0.000181	0.000773	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—PTCH1—muscle cancer	0.00018	0.000771	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—IGF2—muscle cancer	0.000178	0.00076	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—IGF2—muscle cancer	0.000178	0.00076	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD34—muscle cancer	0.000177	0.000755	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—CNR1—muscle cancer	0.000174	0.000744	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—CNR1—muscle cancer	0.000171	0.000732	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD34—muscle cancer	0.000171	0.000731	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD34—muscle cancer	0.000171	0.000731	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—CNR1—muscle cancer	0.000171	0.00073	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—CNR1—muscle cancer	0.00017	0.000728	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—CNR1—muscle cancer	0.00017	0.000726	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—CNR1—muscle cancer	0.000168	0.000719	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000168	0.000717	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—CNR1—muscle cancer	0.000168	0.000717	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—FH—muscle cancer	0.000168	0.000717	CbGpPWpGaD
Promethazine—CALM3—Neuronal System—MDM2—muscle cancer	0.000164	0.000699	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000162	0.000691	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—PTCH1—muscle cancer	0.000161	0.000686	CbGpPWpGaD
Promethazine—CALM3—Signaling by NGF—MDM2—muscle cancer	0.00016	0.000685	CbGpPWpGaD
Promethazine—CALM2—Neuronal System—MDM2—muscle cancer	0.000158	0.000676	CbGpPWpGaD
Promethazine—CALM1—Neuronal System—MDM2—muscle cancer	0.000158	0.000676	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—CNR1—muscle cancer	0.000158	0.000675	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—FH—muscle cancer	0.000158	0.000675	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—FH—muscle cancer	0.000157	0.000669	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—CNR1—muscle cancer	0.000156	0.000665	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—CNR1—muscle cancer	0.000155	0.000663	CbGpPWpGaD
Promethazine—CALM1—Signaling by NGF—MDM2—muscle cancer	0.000155	0.000663	CbGpPWpGaD
Promethazine—CALM2—Signaling by NGF—MDM2—muscle cancer	0.000155	0.000663	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—CNR1—muscle cancer	0.000155	0.000661	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—CNR1—muscle cancer	0.000154	0.000659	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—PTCH1—muscle cancer	0.000154	0.000657	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—PTCH1—muscle cancer	0.000153	0.000654	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—CNR1—muscle cancer	0.000153	0.000652	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—FOXO1—muscle cancer	0.000152	0.000651	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—CNR1—muscle cancer	0.000152	0.000651	CbGpPWpGaD
Promethazine—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.00015	0.000639	CbGpPWpGaD
Promethazine—DRD2—Circadian rythm related genes—TP53—muscle cancer	0.000149	0.000638	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—MED12—muscle cancer	0.000149	0.000638	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PTCH1—muscle cancer	0.000148	0.000632	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PTCH1—muscle cancer	0.000148	0.000632	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—FOXO1—muscle cancer	0.000147	0.00063	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—FOXO1—muscle cancer	0.000147	0.00063	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—FOXO1—muscle cancer	0.000146	0.000625	CbGpPWpGaD
Promethazine—CHRM1—Circadian rythm related genes—TP53—muscle cancer	0.000146	0.000625	CbGpPWpGaD
Promethazine—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000145	0.000619	CbGpPWpGaD
Promethazine—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000145	0.000619	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—FOXO1—muscle cancer	0.000142	0.000605	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—FOXO1—muscle cancer	0.000142	0.000605	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—KIT—muscle cancer	0.000138	0.000592	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—FOXO4—muscle cancer	0.000138	0.00059	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—ENO2—muscle cancer	0.000136	0.000582	CbGpPWpGaD
Promethazine—CALM3—Disease—ENO2—muscle cancer	0.000136	0.000582	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—CNR1—muscle cancer	0.000136	0.000579	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—FOXO4—muscle cancer	0.000132	0.000565	CbGpPWpGaD
Promethazine—CALM1—Disease—ENO2—muscle cancer	0.000132	0.000563	CbGpPWpGaD
Promethazine—CALM2—Disease—ENO2—muscle cancer	0.000132	0.000563	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—CNR1—muscle cancer	0.00013	0.000555	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—CNR1—muscle cancer	0.000129	0.000552	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—MED12—muscle cancer	0.000128	0.000549	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000127	0.000545	CbGpPWpGaD
Promethazine—CALM3—Metabolism—MED12—muscle cancer	0.000125	0.000534	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—CNR1—muscle cancer	0.000125	0.000534	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—CNR1—muscle cancer	0.000125	0.000534	CbGpPWpGaD
Promethazine—CALM3—Disease—HMGA1—muscle cancer	0.000124	0.000529	CbGpPWpGaD
Promethazine—CALM1—Metabolism—MED12—muscle cancer	0.000121	0.000517	CbGpPWpGaD
Promethazine—CALM2—Metabolism—MED12—muscle cancer	0.000121	0.000517	CbGpPWpGaD
Promethazine—CALM3—Immune System—FOXO4—muscle cancer	0.00012	0.000514	CbGpPWpGaD
Promethazine—CALM2—Disease—HMGA1—muscle cancer	0.00012	0.000511	CbGpPWpGaD
Promethazine—CALM1—Disease—HMGA1—muscle cancer	0.00012	0.000511	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—ENO2—muscle cancer	0.000117	0.0005	CbGpPWpGaD
Promethazine—CALM2—Immune System—FOXO4—muscle cancer	0.000116	0.000497	CbGpPWpGaD
Promethazine—CALM1—Immune System—FOXO4—muscle cancer	0.000116	0.000497	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—KIT—muscle cancer	0.000116	0.000496	CbGpPWpGaD
Promethazine—CALM3—Metabolism—ENO2—muscle cancer	0.000114	0.000487	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—KIT—muscle cancer	0.000112	0.00048	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—KIT—muscle cancer	0.000112	0.00048	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—KIT—muscle cancer	0.000111	0.000476	CbGpPWpGaD
Promethazine—CALM3—Disease—FOXO4—muscle cancer	0.000111	0.000474	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IGF2—muscle cancer	0.000111	0.000473	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PTCH1—muscle cancer	0.000111	0.000473	CbGpPWpGaD
Promethazine—CALM2—Metabolism—ENO2—muscle cancer	0.00011	0.000471	CbGpPWpGaD
Promethazine—CALM1—Metabolism—ENO2—muscle cancer	0.00011	0.000471	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—MDM2—muscle cancer	0.000109	0.000466	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PTCH1—muscle cancer	0.000109	0.000465	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PTCH1—muscle cancer	0.000109	0.000464	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PTCH1—muscle cancer	0.000108	0.000463	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PTCH1—muscle cancer	0.000108	0.000461	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—KIT—muscle cancer	0.000108	0.000461	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—KIT—muscle cancer	0.000108	0.000461	CbGpPWpGaD
Promethazine—CALM2—Disease—FOXO4—muscle cancer	0.000107	0.000459	CbGpPWpGaD
Promethazine—CALM1—Disease—FOXO4—muscle cancer	0.000107	0.000459	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PTCH1—muscle cancer	0.000107	0.000457	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	0.000107	0.000455	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IGF2—muscle cancer	0.000106	0.000453	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—FOXO1—muscle cancer	0.000102	0.000436	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—FOXO1—muscle cancer	9.76e-05	0.000417	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	9.63e-05	0.000411	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—FOXO4—muscle cancer	9.51e-05	0.000406	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—MED12—muscle cancer	9.47e-05	0.000405	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—FOXO4—muscle cancer	9.36e-05	0.0004	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—FOXO4—muscle cancer	9.34e-05	0.000399	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CNR1—muscle cancer	9.34e-05	0.000399	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—FOXO4—muscle cancer	9.31e-05	0.000398	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—FOXO4—muscle cancer	9.28e-05	0.000397	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—FOXO4—muscle cancer	9.19e-05	0.000393	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CNR1—muscle cancer	9.19e-05	0.000393	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CNR1—muscle cancer	9.17e-05	0.000392	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	9.16e-05	0.000392	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—MDM2—muscle cancer	9.14e-05	0.000391	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CNR1—muscle cancer	9.14e-05	0.00039	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CNR1—muscle cancer	9.11e-05	0.000389	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTCH1—muscle cancer	9.03e-05	0.000386	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CNR1—muscle cancer	9.02e-05	0.000385	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CNR1—muscle cancer	9e-05	0.000384	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—MED12—muscle cancer	8.93e-05	0.000382	CbGpPWpGaD
Promethazine—CALM3—Immune System—FOXO1—muscle cancer	8.87e-05	0.000379	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—MED12—muscle cancer	8.85e-05	0.000378	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—MDM2—muscle cancer	8.84e-05	0.000378	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—MDM2—muscle cancer	8.84e-05	0.000378	CbGpPWpGaD
Promethazine—CALM3—Adaptive Immune System—MDM2—muscle cancer	8.78e-05	0.000375	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTCH1—muscle cancer	8.74e-05	0.000373	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTCH1—muscle cancer	8.74e-05	0.000373	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ENO2—muscle cancer	8.64e-05	0.000369	CbGpPWpGaD
Promethazine—CALM1—Immune System—FOXO1—muscle cancer	8.58e-05	0.000367	CbGpPWpGaD
Promethazine—CALM2—Immune System—FOXO1—muscle cancer	8.58e-05	0.000367	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—MDM2—muscle cancer	8.49e-05	0.000363	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—MDM2—muscle cancer	8.49e-05	0.000363	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—VEGFA—muscle cancer	8.28e-05	0.000354	CbGpPWpGaD
Promethazine—CALM3—Disease—FOXO1—muscle cancer	8.19e-05	0.00035	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ENO2—muscle cancer	8.14e-05	0.000348	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ENO2—muscle cancer	8.07e-05	0.000345	CbGpPWpGaD
Promethazine—CALM2—Disease—FOXO1—muscle cancer	7.93e-05	0.000339	CbGpPWpGaD
Promethazine—CALM1—Disease—FOXO1—muscle cancer	7.93e-05	0.000339	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—FOXO4—muscle cancer	7.77e-05	0.000332	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—KIT—muscle cancer	7.77e-05	0.000332	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—VEGFA—muscle cancer	7.71e-05	0.00033	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IGF2—muscle cancer	7.63e-05	0.000326	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CNR1—muscle cancer	7.63e-05	0.000326	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—FOXO4—muscle cancer	7.52e-05	0.000321	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—FOXO4—muscle cancer	7.52e-05	0.000321	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IGF2—muscle cancer	7.51e-05	0.000321	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IGF2—muscle cancer	7.49e-05	0.00032	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IGF2—muscle cancer	7.47e-05	0.000319	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—VEGFA—muscle cancer	7.46e-05	0.000319	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—VEGFA—muscle cancer	7.46e-05	0.000319	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IGF2—muscle cancer	7.45e-05	0.000318	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—KIT—muscle cancer	7.44e-05	0.000318	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CNR1—muscle cancer	7.38e-05	0.000315	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CNR1—muscle cancer	7.38e-05	0.000315	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IGF2—muscle cancer	7.37e-05	0.000315	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IGF2—muscle cancer	7.35e-05	0.000314	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—FOXO1—muscle cancer	7.02e-05	0.0003	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—FOXO1—muscle cancer	6.91e-05	0.000295	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—FOXO1—muscle cancer	6.9e-05	0.000295	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—FOXO1—muscle cancer	6.88e-05	0.000294	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—FOXO1—muscle cancer	6.85e-05	0.000293	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—FOXO1—muscle cancer	6.79e-05	0.00029	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	6.77e-05	0.000289	CbGpPWpGaD
Promethazine—CALM3—Immune System—KIT—muscle cancer	6.76e-05	0.000289	CbGpPWpGaD
Promethazine—CALM2—Immune System—KIT—muscle cancer	6.54e-05	0.00028	CbGpPWpGaD
Promethazine—CALM1—Immune System—KIT—muscle cancer	6.54e-05	0.00028	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.31e-05	0.00027	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—TP53—muscle cancer	6.26e-05	0.000267	CbGpPWpGaD
Promethazine—CALM3—Disease—KIT—muscle cancer	6.24e-05	0.000267	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IGF2—muscle cancer	6.23e-05	0.000266	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MDM2—muscle cancer	6.12e-05	0.000261	CbGpPWpGaD
Promethazine—CALM1—Disease—KIT—muscle cancer	6.04e-05	0.000258	CbGpPWpGaD
Promethazine—CALM2—Disease—KIT—muscle cancer	6.04e-05	0.000258	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IGF2—muscle cancer	6.03e-05	0.000258	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IGF2—muscle cancer	6.03e-05	0.000258	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MDM2—muscle cancer	5.86e-05	0.00025	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—TP53—muscle cancer	5.83e-05	0.000249	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—FOXO1—muscle cancer	5.74e-05	0.000245	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—TP53—muscle cancer	5.64e-05	0.000241	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—TP53—muscle cancer	5.64e-05	0.000241	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—FOXO1—muscle cancer	5.55e-05	0.000237	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—FOXO1—muscle cancer	5.55e-05	0.000237	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KIT—muscle cancer	5.35e-05	0.000229	CbGpPWpGaD
Promethazine—CALM3—Immune System—MDM2—muscle cancer	5.33e-05	0.000228	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KIT—muscle cancer	5.27e-05	0.000225	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KIT—muscle cancer	5.26e-05	0.000225	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KIT—muscle cancer	5.24e-05	0.000224	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KIT—muscle cancer	5.22e-05	0.000223	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KIT—muscle cancer	5.17e-05	0.000221	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KIT—muscle cancer	5.16e-05	0.00022	CbGpPWpGaD
Promethazine—CALM1—Immune System—MDM2—muscle cancer	5.15e-05	0.00022	CbGpPWpGaD
Promethazine—CALM2—Immune System—MDM2—muscle cancer	5.15e-05	0.00022	CbGpPWpGaD
Promethazine—CALM3—Disease—MDM2—muscle cancer	4.92e-05	0.00021	CbGpPWpGaD
Promethazine—CALM2—Disease—MDM2—muscle cancer	4.76e-05	0.000203	CbGpPWpGaD
Promethazine—CALM1—Disease—MDM2—muscle cancer	4.76e-05	0.000203	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PTGS2—muscle cancer	4.74e-05	0.000203	CbGpPWpGaD
Promethazine—CALM3—Disease—PTGS2—muscle cancer	4.74e-05	0.000203	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—VEGFA—muscle cancer	4.65e-05	0.000199	CbGpPWpGaD
Promethazine—CALM1—Disease—PTGS2—muscle cancer	4.59e-05	0.000196	CbGpPWpGaD
Promethazine—CALM2—Disease—PTGS2—muscle cancer	4.59e-05	0.000196	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—VEGFA—muscle cancer	4.45e-05	0.00019	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KIT—muscle cancer	4.37e-05	0.000187	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KIT—muscle cancer	4.23e-05	0.000181	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KIT—muscle cancer	4.23e-05	0.000181	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MDM2—muscle cancer	4.22e-05	0.00018	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MDM2—muscle cancer	4.15e-05	0.000177	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MDM2—muscle cancer	4.14e-05	0.000177	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MDM2—muscle cancer	4.13e-05	0.000176	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MDM2—muscle cancer	4.11e-05	0.000176	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTGS2—muscle cancer	4.08e-05	0.000174	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MDM2—muscle cancer	4.07e-05	0.000174	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MDM2—muscle cancer	4.06e-05	0.000174	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTGS2—muscle cancer	3.97e-05	0.00017	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTGS2—muscle cancer	3.84e-05	0.000164	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTGS2—muscle cancer	3.84e-05	0.000164	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—muscle cancer	3.51e-05	0.00015	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MDM2—muscle cancer	3.44e-05	0.000147	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—muscle cancer	3.36e-05	0.000144	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MDM2—muscle cancer	3.33e-05	0.000142	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MDM2—muscle cancer	3.33e-05	0.000142	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—muscle cancer	3.2e-05	0.000137	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—muscle cancer	3.15e-05	0.000135	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—muscle cancer	3.14e-05	0.000134	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—muscle cancer	3.13e-05	0.000134	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—muscle cancer	3.12e-05	0.000133	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—muscle cancer	3.09e-05	0.000132	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	3.08e-05	0.000132	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—muscle cancer	3.01e-05	0.000129	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—muscle cancer	2.84e-05	0.000121	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—muscle cancer	2.81e-05	0.00012	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—muscle cancer	2.61e-05	0.000112	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—muscle cancer	2.53e-05	0.000108	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—muscle cancer	2.53e-05	0.000108	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—muscle cancer	2.42e-05	0.000103	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—muscle cancer	2.38e-05	0.000102	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—muscle cancer	2.37e-05	0.000101	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—muscle cancer	2.37e-05	0.000101	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—muscle cancer	2.36e-05	0.000101	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—muscle cancer	2.34e-05	9.99e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—muscle cancer	2.33e-05	9.96e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—muscle cancer	1.98e-05	8.44e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—muscle cancer	1.91e-05	8.17e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—muscle cancer	1.91e-05	8.17e-05	CbGpPWpGaD
